We hypothesized that 6-HMDN exerts anti-tumor activity via multiple key pathways, including modulation of apoptosis-related proteins, reactive oxygen species (ROS) levels, ferroptosis markers, and the phosphorylation status of focal adhesion kinase (FAK). Here, PTK2 is linked to neoplasm.